History Day Previous Topics

Listed here are U.S. and other laws and regulations. Various countries and organizations may have different details in the legal documents.

United States

Additional countries and organizations

These are outside of the Connecticut State Library's collections.

See also Orphan Drugs under Medical & Life Sciences.

• Congressional Record, V. 149, PT. 9, May 14, 2003 to May 21, 2003 - May 19 page 12115 available on FDSys or in print

• Congressional Record Volume 153, Number 156 (Tuesday, October 16, 2007). Extensions of Remarks. Page E2152.  TRIBUTE TO ABBEY MEYERS.  From the Congressional Record Online through the Government Printing Office.  Print on Level 6 of State Library

• "3. The Food and Drug Administration’s Orphan Drug Program: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation.  Washington (DC): National Academies Press (US); 2009.  Connect to http://www.ncbi.nlm.nih.gov/books/NBK50977 

• "WHERE TO DRAW THE BOTTOM LINE: FINANCIAL CONFLICT OF INTEREST IN CLINICAL RESEARCH." by Fran Pollner The NIH Catalyst STLib Fed Docs HE 20.3061:v/no 

NIH Search results:

NOT at State Library

• Special Emphasis Panel of the National Institutes of Health on the Coordination of Rare Diseases Research http://rarediseases.info.nih.gov/asp/html/reports/fy1999/sep.html

• Abbey Meyers: The "Mother" of Invention. Pharmaceutical Executive. Oct 01, 2011  By Jennifer Ringler

• Printout given to patron http://www.hhs.gov/ohrp/archive/nhrpac/meyers.pdf

• Forwarded Letters of Abbey Meyers - printout given to patron  http://www.fda.gov/ohrms/dockets/dailys/04/july04/072204/03P-0039-emc00001-01.pdf

• NORD. A beacon of hope for people with rare disorders - printout given to patron - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994497/pdf/rt-2010-1-e13.pdf

• The Center for Rare and Neglected Diseases at the University of Notre Dame http://www3.nd.edu/~crnd/CTSS7Dunkle.htm

• Rare Diseases in the Age of Health 2.0.   By Rajeev K. Bali, Lodewijk Bos, Michael Christopher Gibbons, Simon R. Ibell.  p.133 has timeline that includes major accomplishments by NORD https://books.google.com/books?id=F-a9BAAAQBAJ&lpg=PA133&ots=eHiTuiA6Q5&dq=%22Abbey%20Meyers%22%20NORD&pg=PA133#v=onepage&q=%22Abbey%20Meyers%22%20NORD&f=false

•  

Abbey Meyers (Abbey S. Meyers) founded the organization.

• Orphan drug reauthorization : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994.   StLib Federal Documents Y 4.EN 2/3:103-113   AVAILABLE
• Orphan Drug Amendments of 1994 : report together with additional views (to accompany S. 1981).  STLib Fed Docs Y 1.1/2:Serial 14227 and StLib Fed Doc Microfiche  Y 1.1/5:103-366  also http://www.gpo.gov/fdsys/pkg/BILLS-103s1981rs/html/BILLS-103s1981rs.htm
• Henkel, John (1999). "Orphan Drug Law Matures into Medical Mainstay". FDA Consumer.  STLib Fed Docs HE 20.4010: 
• NORD profile on GuideStar (via Wikipedia). http://www.guidestar.org/PartnerReport.aspx?partner=justgivews&ein=13-3223946